S-Nitrosoglutathione
SIGMA/N4148 - ≥97%
Synonym: GSNO; SNOG
CAS Number: 57564-91-7
Empirical Formula (Hill Notation): C10H16N4O7S
Molecular Weight: 336.32
MDL Number: MFCD00214341
Linear Formula: C10H16N4O7S
Product Type: Chemical
| assay | ≥97% |
| form | powder |
| InChI | 1S/C10H16N4O7S/c11-5(10(1 |
| InChI key | HYHSBSXUHZOYLX-WDSKDSINSA |
| Quality Level | 200 ![]() |
| SMILES string | N[C@@H](CCC(=O)N[C@@H](CS |
| solubility | water: soluble 19.60-20.40 mg/mL |
| storage temp. | −20°C |
| Application: | S-Nitrosoglutathione (GSNO) has been used: • as a standard in reversed phase chromatography coupled to chemical vapour generation and atomic fluorescence detector (RPC-CVGAFS) and reversed phase chromatography fluorimetric (RPC-FD). • as a standard in spectrophotometric and high-performance liquid chromatography (HPLC) assay. |
| Biochem/physiol Actions: | S-Nitrosoglutathione (GSNO) inhibits the activity of sarcoplasmic reticulum-bound creatine kinase in rabbit skeletal muscle and eventually reduces ATP driven Ca2+ uptake in sarcoplasmic reticulum vesicles. GSNO in airway cells relaxes airway smooth muscle and enhances airway ciliary motility. It also blocks airway epithelial amiloride-sensitive sodium transport while stimulating calcium-dependent epithelial chloride transport and induces neutrophilic apoptosis. In addition, it also has antimicrobial activity. GSNO concentration is low in cystic fibrosis (CF) airway. It is an NO donor, acts as a smooth muscle relaxant, vasodilator and inhibits platelet activation in vivo. |
| General description: | S-Nitrosoglutathione (GSNO) is an endogenous nitrogen oxide and is highly distributed in extracellular fluids of the lung and brain. |
| Packaging: | 25 mg in poly bottle |
| Packaging: | 50 mg in glass bottle |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | ≥97% |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

